[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 3].
D014151:Anti-Anxiety Agents; D001008:Anxiety Disorders / Q000188:drug therapy; D001569:Benzodiazepines; D001570:Benzodiazepinones / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D000078306:Clobazam; D002997:Clomipramine / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003006:Clopenthixol / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D006801:Humans; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D014149:Tranquilizing Agents; D001569:Benzodiazepines; D000078306:Clobazam; D002998:Clonazepam; D003006:Clopenthixol; D002749:Chlorprothixene; D002997:Clomipramine
Die ataraktische Behandlung in Psychiatrie und Allgemeinmedizin.